nepafenac has been researched along with Uveitis, Anterior in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Cagini, C; Cerquaglia, A; Fiore, T; Iaccheri, B; Lupidi, M; Pellegrino, A | 1 |
Artzen, D; Laurell, CG; Montan, P; Stenevi, U; Zaczek, A | 1 |
Holland, EJ; Lane, SS; Lehmann, RP; Modi, SS | 1 |
Chalkley, TH; Duong, HV; Westfield, KC | 1 |
McCulley, JP | 1 |
4 trial(s) available for nepafenac and Uveitis, Anterior
Article | Year |
---|---|
Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzeneacetamides; Diclofenac; Double-Blind Method; Female; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Prospective Studies; Pseudophakia; Slit Lamp Microscopy; Uveitis, Anterior; Visual Acuity | 2020 |
Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Uveitis, Anterior; Visual Acuity | 2014 |
Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phacoemulsification; Phenylacetates; Uveitis, Anterior; Visual Acuity | 2007 |
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Female; Humans; Ketorolac Tromethamine; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Pain, Postoperative; Patient Compliance; Patient Satisfaction; Phacoemulsification; Phenylacetates; Prospective Studies; Uveitis, Anterior; Visual Acuity | 2007 |
1 other study(ies) available for nepafenac and Uveitis, Anterior
Article | Year |
---|---|
Ketorolac versus nepafenac in cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Humans; Ketorolac Tromethamine; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Ophthalmic Solutions; Pain, Postoperative; Patient Compliance; Patient Satisfaction; Phacoemulsification; Phenylacetates; Uveitis, Anterior; Visual Acuity | 2008 |